ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Texas » Internal Medicine

Top Internal Medicine Prescribers in Texas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
PAUL WELLS M.D.

Internal Medicine

15,450

$789K

520
421 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$51
Average prescription price

Avg: $67

STELLA YU M.D.

Internal Medicine

15,423

$1.02M

551
472 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

23%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$66
Average prescription price

Avg: $67

MONZER YAZJI MD

Internal Medicine

15,398

$1.52M

1113
780 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$98
Average prescription price

Avg: $67

MANUEL MARTINEZ M.D.

Internal Medicine

15,391

$1.1M

659
487 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $67

NATHAN WATSON MD

Internal Medicine

15,353

$878K

465
385 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 27%

$57
Average prescription price

Avg: $67

TRAM HO MD

Internal Medicine

15,348

$1.34M

751
654 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 27%

$87
Average prescription price

Avg: $67

JOHN LEVINS M.D.

Internal Medicine

15,315

$1.2M

671
625 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$78
Average prescription price

Avg: $67

BILL BALCH MD

Internal Medicine

15,307

$684K

665
538 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

27%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 27%

$45
Average prescription price

Avg: $67

RONALD BRUCE D.O.

Internal Medicine

15,251

$849K

527
446 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

ERNEST WHITE MD

Internal Medicine

15,169

$1.27M

725
467 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $67

SRINIVAS RANGU M.D.

Internal Medicine

15,146

$905K

678
602 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

11%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 27%

$60
Average prescription price

Avg: $67

RODNEY SLONE M.D.

Internal Medicine

15,145

$752K

753
680 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

13%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

CESAR ALBARRACIN MD

Internal Medicine

15,119

$804K

652
538 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

MANOJ PATEL MD

Internal Medicine

15,089

$835K

506
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

22%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$55
Average prescription price

Avg: $67

POLLACHI SELVAKUMARRAJ MD

Internal Medicine

15,063

$730K

449
366 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

17%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$48
Average prescription price

Avg: $67

MICHELLE MENDOZA M.D.

Internal Medicine

15,049

$192K

454
392 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$13
Average prescription price

Avg: $67

SALMAN AHMAD MD

Internal Medicine

15,032

$805K

655
484 are 65+

4%
patients receiving schedule two controlled substances

Avg: 1%

20%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$54
Average prescription price

Avg: $67

ROBERT TAVERA MD

Internal Medicine

15,016

$702K

571
476 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

21%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$47
Average prescription price

Avg: $67

HIMA RAVI MD

Internal Medicine

14,997

$753K

526
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

25%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

TED TRULY MD

Internal Medicine

14,964

$726K

633
550 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

14%
patients receiving schedule three controlled substances

Avg: 15%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 27%

$49
Average prescription price

Avg: $67

ALKESH AMIN MD

Internal Medicine

14,963

$747K

507
445 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

19%
patients receiving schedule three controlled substances

Avg: 15%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$50
Average prescription price

Avg: $67

VICTOR VLAHAKOS MD

Internal Medicine

14,944

$908K

979
665 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

33%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

MANGALA RAMAMURTHY M.D.

Internal Medicine

14,940

$910K

544
396 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 15%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 27%

$61
Average prescription price

Avg: $67

MARK SIJ D.O.

Internal Medicine

14,932

$837K

650
508 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

24%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 27%

$56
Average prescription price

Avg: $67

WILLIAM COUCH MD

Internal Medicine

14,918

$795K

825
754 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 15%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 27%

$53
Average prescription price

Avg: $67

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank